Market News How it works Learn FAQ
| RCT 0.0923 21.29% | NU 12.5021 -17.53% | EWZ 34.02 -20.12% | BBD 2.877 -29.31% | TGL 0.2429 9.66% | AZTR 2.05 186.71% | ITUB 7.68 -20.58% | SRTM 0.2775 -35.51% | NVD 3.995 -4.65% | XP 15.4801 -49.10% | WFF 0.089 11.25% | SHFS 0.091 -31.27% | SPCX 149.37 1.27% | SOXL 92.37 10.54% | PBR 22.715 -13.17% | VALE 11.99 -3.31% | CLRO 4.84 48.92% | INTC 91.75 5.51% | GCDT 0.1443 -18.06% | TSLL 10.885 11.53% | NWGL 0.0872 6.34% | NOK 8.715 7.06% | NVDA 216.1126 2.44% | SOXS 46.95 -10.50% | CRWV 56.22 3.66% | BITO 10.695 -1.25% | RWM 14.475 -0.52% | GPUS 0.1858 10.01% | SGRY 23.185 47.21% | TSLG 5.445 11.81% | ABEV 2.805 -15.00% | JBLU 2.285 -12.95% | IREN 26.025 4.50% | INTR 4.595 -36.09% | RBNE 0.1682 -11.47% | QID 14.1701 -2.61% | AAL 12.1792 0.57% | TQQQ 68.8286 3.83% | SBS 4.6303 -27.65% | SPDN 8.485 -0.64% | TSLA 393.84 5.81% | T 20.6998 -1.10% | LUCD 0.538 30.90% | SID 0.9075 -23.09% | WULF 12.3201 8.83% | XTND 2.2899 29.37% | NFLX 63.005 -4.32% | CIFR 7.885 -0.69% | SQQQ 38.17 -3.81% | RIG 6.555 2.26%
SNSonoma Pharmaceuticals, Inc. logo

Sonoma Pharmaceuticals, Inc. (SNOA)

NASDAQ Capital Market · Currency in USD
$1.10 ▼ -0.01 (-0.90%)
As of Oct 26, 2:23 PM ET. Market open.

Summary

Previous Close
$1.11
Open
$1.12
Day's Range
$1.10 – $1.20
52 Week Range
$0.85 – $4.10
Volume
57,370
Avg. Volume
104,883
Market Cap
$5.27M
Beta (5Y Monthly)
1.30
PE Ratio (TTM)
--
EPS (TTM)
-$0.59
Earnings Date
Nov 16, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: Sonoma Pharmaceuticals, Inc.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Full-time employees
10
CEO
Amy Trombly

Sonoma Pharmaceuticals, Inc. specializes in the creation and distribution of stabilized hypochlorous acid (HOCl) products. These offerings address a diverse range of medical and health needs, including wound management, veterinary care, ocular hygiene, oral health, and various dermatological conditions. The company's market reach extends across the United States, Latin America, Europe, and other international territories.

Earnings

Next report: Mon, Nov 16, 2026
EPS estimate -$0.10 · Revenue est. $5.29M
DateEst.Actual
Aug 6, 2026-$0.30$0.02Beat
Jun 16, 2026-$0.24-$0.33Miss
Feb 4, 2026-$0.29-$0.48Miss
Nov 6, 2025-$0.31-$0.32Miss
Aug 7, 2025-$0.51-$0.76Miss
Jun 16, 2025-$0.73-$0.15Beat

Analyst view

Rating: Buy
Buy 50% · Hold 50% · Sell 0%

Get free alerts on SNOA and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.